[{"address1": "500 West 5th Street", "address2": "Suite 1200", "city": "Austin", "state": "TX", "zip": "78701", "country": "United States", "phone": "512 900 4690", "website": "https://www.shattucklabs.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. The company was incorporated in 2016 and is headquartered in Austin, Texas.", "fullTimeEmployees": 105, "companyOfficers": [{"maxAge": 1, "name": "Dr. Taylor H. Schreiber M.D., Ph.D.", "age": 42, "title": "Co-Founder, CEO & Director", "yearBorn": 1980, "fiscalYear": 2022, "totalPay": 783745, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Abhinav A. Shukla Ph.D.", "age": 49, "title": "Chief Technical Officer", "yearBorn": 1973, "fiscalYear": 2022, "totalPay": 567398, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Arundathy Nirmalini Pandite M.B.A., M.D.", "age": 63, "title": "Chief Medical Officer", "yearBorn": 1959, "fiscalYear": 2022, "totalPay": 678764, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew R. Neill M.B.A.", "age": 36, "title": "Chief Financial Officer", "yearBorn": 1986, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Conor  Richardson CPA", "title": "Vice President of Investor Relations", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen  Stout J.D., Ph.D.", "title": "General Counsel, Corporate Secretary and Chief Ethics & Compliance Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Casi  DeYoung", "age": 51, "title": "Chief Business Officer", "yearBorn": 1971, "fiscalYear": 2022, "totalPay": 523482, "exercisedValue": 0, "unexercisedValue": 493071}, {"maxAge": 1, "name": "Dr. Thomas  Lampkin Pharm.D.", "title": "Senior Vice President of Regulatory Affairs", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. George  Fromm Ph.D.", "title": "Chief Scientific Officer of ARC Platform", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Suresh de Silva Ph.D.", "title": "Chief Scientific Officer of GADLEN Platform", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 3, "boardRisk": 6, "compensationRisk": 7, "shareHolderRightsRisk": 8, "overallRisk": 6, "governanceEpochDate": 1701388800, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 2, "previousClose": 6.96, "open": 6.73, "dayLow": 5.9301, "dayHigh": 7.43, "regularMarketPreviousClose": 6.96, "regularMarketOpen": 6.73, "regularMarketDayLow": 5.9301, "regularMarketDayHigh": 7.43, "payoutRatio": 0.0, "beta": 1.336, "forwardPE": -3.4607332, "volume": 6769762, "regularMarketVolume": 6769762, "averageVolume": 1308015, "averageVolume10days": 7929380, "averageDailyVolume10Day": 7929380, "bid": 6.47, "ask": 6.7, "bidSize": 1100, "askSize": 3000, "marketCap": 280829152, "fiftyTwoWeekLow": 1.33, "fiftyTwoWeekHigh": 7.5, "priceToSalesTrailing12Months": 210.67453, "fiftyDayAverage": 2.03724, "twoHundredDayAverage": 2.490485, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "enterpriseValue": 184141056, "profitMargins": 0.0, "floatShares": 30646905, "sharesOutstanding": 42485500, "sharesShort": 316323, "sharesShortPriorMonth": 294606, "sharesShortPreviousMonthDate": 1698710400, "dateShortInterest": 1701302400, "sharesPercentSharesOut": 0.0074, "heldPercentInsiders": 0.14445, "heldPercentInstitutions": 0.48104998, "shortRatio": 5.65, "shortPercentOfFloat": 0.0116, "impliedSharesOutstanding": 42485500, "bookValue": 2.655, "priceToBook": 2.4896421, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -95022000, "trailingEps": -2.24, "forwardEps": -1.91, "enterpriseToRevenue": 138.14, "enterpriseToEbitda": -1.934, "52WeekChange": 1.7839999, "SandP52WeekChange": 0.23624158, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "STTK", "underlyingSymbol": "STTK", "shortName": "Shattuck Labs, Inc.", "longName": "Shattuck Labs, Inc.", "firstTradeDateEpochUtc": 1602250200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "64a83d67-d0cd-3885-8206-d0f94edae33a", "messageBoardId": "finmb_378179277", "gmtOffSetMilliseconds": -18000000, "currentPrice": 6.61, "targetHighPrice": 28.0, "targetLowPrice": 4.0, "targetMeanPrice": 12.8, "targetMedianPrice": 12.0, "recommendationMean": 1.7, "recommendationKey": "buy", "numberOfAnalystOpinions": 5, "totalCash": 101074000, "totalCashPerShare": 2.379, "ebitda": -95216000, "totalDebt": 4386000, "quickRatio": 7.189, "currentRatio": 8.037, "totalRevenue": 1333000, "debtToEquity": 3.889, "revenuePerShare": 0.031, "returnOnAssets": -0.35117, "returnOnEquity": -0.60872, "grossProfits": -82247000, "freeCashflow": -52760248, "operatingCashflow": -85650000, "revenueGrowth": 2.236, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -41.688053, "financialCurrency": "USD", "trailingPegRatio": null}]